NMRA vs UPST · $283.5M cap vs P/E 74, rev $636.5M
Neumora Therapeutics, Inc. (NMRA) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
NMRA does not have a complete income-statement cache yet.
Latest reported UPST revenue for 2024-12-31 was $636.5M. Net income was -$128.6M. Revenue was up 23.9% from 2023-12-31 to 2024-12-31. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
NMRA currently screens at market cap $283.5M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the NMRA and UPST stock pages for the full models.
Not investment advice.